在炎症性肠病中免疫通路的转化性表征:针对性治疗的见解
Sabrina Nicolò1,2, Ilaria Faggiani1,2, Carmela Errico1,2
1Department of Gastroenterology and Digestive Endoscopy, IRCCS Ospedale San Raffaele, Milan, Italy.
炎症性肠道疾病 (IBD) 治疗已经进步,生物药物向瘤坏死因子-α (TNF-α) 和其他途径. 持续的研究对于难以治疗的IBD病例和新的治疗目标至关重要.
科学领域:
- 胃肠道学和免疫学
- 药理学和药物开发领域
背景情况:
- 炎症性肠病 (IBD) 的发病过程涉及复杂的,失调的炎症路径.
- 了解这些分子机制对于开发向疗法至关重要.
研究的目的:
- 审查IBD病变发生过程中的关键分子标.
- 批判性地评估IBD的先进治疗药物的发展.
- 讨论成功和失败的药物开发计划.
主要方法:
- 对IBD研究和临床试验进行全面的PubMed文献搜索.
- 分析基础科学发现和临床试验数据.
- 对针对炎症途径,整蛋白和白细胞贩运的治疗剂的审查.
主要成果:
- 针对瘤坏死因子-α (TNF-α),整体蛋白和S1P调节剂的生物药物的开发扩大了IBD治疗选择.
- 像IL-12/IL-23和JAK抑制剂这样的新药显示出强大的疗效和安全性.
- 在管理和治疗耐火性IBD病例方面仍然存在重大挑战.
结论:
- 治疗IBD的治疗场景随着有针对性的生物疗法显著发展.
- 进一步的研究是必要的,以确定新的目标,并改善所有IBD患者的结果,特别是那些难以治疗的疾病.
更多相关视频
08:37Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
07:05Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
